Revolution Medicines, Inc.
- Last sale
- Nov 12, 2026 · -2.40%
- Market cap
- $38.14B
- 216.29M shares
- Filings
- 871
Q3 2026
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026−29.3% FY25 yoy
- $38.14B
- —
- —
- 15.9×
- -2.40%
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $0 | reported | |
| FY 2024 | 2024-12-31 | $0 | reported | |
| FY 2023 | 2023-12-31 | $11,580,000 | reported | |
| FY 2022 | 2022-12-31 | $35,380,000 | reported | |
| FY 2021 | 2021-12-31 | $29,390,000 | reported | |
| FY 2020 | 2020-12-31 | $42,983,000 | reported | |
| FY 2019 | 2019-12-31 | $50,041,000 | reported | |
| FY 2018 | 2018-12-31 | $20,165,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2020 | $0.00 | — | $0.00 | — | 73.38M sh | +2,129.1% | — |
Segments
Products
LineFY2022ShareChange
Collaboration Revenue$35.38M100%+20.4%
Collaboration Revenue, Other———
Collaboration Revenue, Related Party———
Total$35.38M
Biological products, except diagnostic substances
Revolution Medicines, Inc. is the 5th largest of the 176 covered companies the SEC files under this code, by market cap. SIC 2836
CompanyRevenueGrowthNet marginMarket cap
MRNAModerna, Inc.$1.9B39.9%145.2%$93.6BARGXArgenx SE———$60.7B
RVMDRevolution Medicines, Inc. (this company)$0.0——$38.1B
BIIBBiogen Inc.$9.9B2.2%13.1%$37.0BBNTXBioNTech SE———$21.5BNBIXNeurocrine Biosciences Inc$2.9B21.4%16.7%$17.1BEXELExelixis, Inc.$2.3B7.0%33.7%$17.0BHALOHalozyme Therapeutics, Inc.$1.4B37.6%22.7%$11.5BTECHBio-Techne Corp$1.2B0.4%15.0%$11.4BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Revolution Medicines, Inc. · CIK 1628171 · Engraved from SEC EDGAR